These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Ishikawa H; Matsumoto S; Ohashi Y; Imaoka A; Setoyama H; Umesaki Y; Tanaka R; Otani T Digestion; 2011; 84(2):128-33. PubMed ID: 21525768 [TBL] [Abstract][Full Text] [Related]
5. Probiotics, prebiotics and antibiotics in inflammatory bowel disease. Cummings JH; Kong SC Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637 [TBL] [Abstract][Full Text] [Related]
6. Prebiotics and probiotics in ulcerative colitis: where do we stand? Rogler G Digestion; 2011; 84(2):126-7. PubMed ID: 21494044 [No Abstract] [Full Text] [Related]
7. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Fujimori S; Gudis K; Mitsui K; Seo T; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C Nutrition; 2009 May; 25(5):520-5. PubMed ID: 19201576 [TBL] [Abstract][Full Text] [Related]
8. The role of the intestinal microflora for the development of the immune system in early childhood. Ouwehand A; Isolauri E; Salminen S Eur J Nutr; 2002 Nov; 41 Suppl 1():I32-7. PubMed ID: 12420114 [TBL] [Abstract][Full Text] [Related]
9. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Bai AP; Ouyang Q; Xiao XR; Li SF Int J Clin Pract; 2006 Mar; 60(3):284-8. PubMed ID: 16494642 [TBL] [Abstract][Full Text] [Related]
10. Probiotics and prebiotics in ulcerative colitis. Derikx LA; Dieleman LA; Hoentjen F Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):55-71. PubMed ID: 27048897 [TBL] [Abstract][Full Text] [Related]
11. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....]. Duchmann R; Lochs H; Kruis W MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626 [TBL] [Abstract][Full Text] [Related]
12. Intestinal microflora as a therapeutic target in inflammatory bowel disease. Mitsuyama K; Toyonaga A; Sata M J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870 [TBL] [Abstract][Full Text] [Related]
13. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
14. VSL#3 and remission in active ulcerative colitis: larger studies required. Jackson EL; Hamlin PJ; Ford AC Am J Gastroenterol; 2011 Mar; 106(3):547; author reply 547-8. PubMed ID: 21378771 [No Abstract] [Full Text] [Related]
15. Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis. Haskey N; Dahl WJ Nutr Rev; 2006 Mar; 64(3):132-8. PubMed ID: 16572600 [TBL] [Abstract][Full Text] [Related]
16. [Comparative assessment of intestinal microflora in Crohn's disease and non-specific ulcerative colitis]. Marko OP; Levitan MKh; Turovtseva VV; Dzhimbeev VL Klin Med (Mosk); 1977; 55(1):95-100. PubMed ID: 839703 [No Abstract] [Full Text] [Related]
17. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Prantera C; Scribano ML Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096 [TBL] [Abstract][Full Text] [Related]
19. The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum. Guo J; Li L; Cai Y; Kang Y Cell Commun Signal; 2024 May; 22(1):268. PubMed ID: 38745207 [TBL] [Abstract][Full Text] [Related]